Aspirin And Extended-release Dipyridamole Capsule
Product Images NDC 42291-116

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended-release Dipyridamole (NDC 42291-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 200 (116 60 25mg 200mg)

Aspirin and extended-release Dipyridamole capsules are available in unit-of-use containers of 60 capsules. Each capsule contains 200mg dipyridamole in extended-release form and 25mg aspirin in immediate-release sugar-coated tablet form. The usual dosage is available in the accompanying prescription information. It is a prescription medication and should be stored between 20 C to 25C (68F to 77F) and can be excused between 15C to 30C (59F to 86F). Manufactured by Amneal Pharmaceuticals of NY, LLC and is distributed by AVKARE with the latest revision done in January 2019. It is important to keep them away from children and protect them from excessive moisture.*

FDA Label Image

Chem Struc Dp (Aspirin And Extended Release Dipyridamole Capsules 1)

This is a chemical compound with a molecular weight of 504.63 g/mol and its chemical formula is C24H40Ng0O4. It is not clear what the compound's name or purpose is as only the chemical formula and molecular weight are provided.*

FDA Label Image

Chem Struc Asp (Aspirin And Extended Release Dipyridamole Capsules 2)

FDA Label Image

Figure 1 (Aspirin And Extended Release Dipyridamole Capsules 3)

This is a graph showing the cumulative stroke rate for different treatment groups over a period of 26 months. The treatment groups include aspirin and extended-release dipyridamole (ER-DP) and placebo. The dosage regimen for all groups is b.i.d. (twice a day). The x-axis represents the months of follow-up and the y-axis represents the percentage of cumulative stroke rate.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.